Table 1.
Characteristic | Number of patients (%) |
Age (y) | 67 |
Range | 25–77 |
Karnofsky performance status | |
70 | 1 (11) |
80 | 8 (89) |
Type of cancer | |
Renal cell carcinoma | 2 (22) |
Bladder urothelial carcinoma | 2 (22) |
Prostate adenocarcinoma | 2 (22) |
Gastroesophageal adenocarcinoma | 1 (11) |
Mesothelioma | 1 (11) |
Sarcoma | 1 (11) |
Prior therapy | |
Chemotherapy | 8 (89) |
Radiotherapy | 3 (33) |
Immunotherapy | 1 (11) |
Hormonal | 2 (22) |
Surgical | 4 (44) |
Other | 7 (78) |